Concerns over the safety of the popular type 2 diabetes drug Avandia® are once again are in the news, thanks to new revelations from a Senate committee reported in the New York Times. According to the article, Food and Drug Administration (FDA) officials are recommending that Avandia® be pulled from the market due to its potential harm to the heart.
“Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market.”
PLEASE NOTE: Patients should continue taking Avandia® unless told by their healthcare professional to stop. Patients who are concerned about the possible risks associated with using Avandia® should talk to their healthcare professional.
To discuss your potential claim with an attorney, contact the Maher Law Firm. Our personal injury lawyers are currently investigating cases involving Avandia® side effects.
FDA reports suggest that if every diabetic currently taking Avandia® switched Actos, a similar pill, about 500 heart attacks and 300 cases of hear failure would be averted each month.
The Avandia® controversy has been brewing for years but has been brought to a head by a new clinical trial and a Senate investigation that concluded Avandia®’s maker, GlaxoSmithKline, should have warned patients earlier of the drug’s potential risks.
“The bipartisan multiyear Senate investigation sharply criticizes GlaxoSmithKline, saying it failed to warn patients years earlier that Avandia was potentially deadly (New York Times).”
Possible Avandia® health risks surfaced in 2007 when Cleveland Clinic cardiologist Steve Nissen published a study in the New England Journal of Medicine that found Avandia® users were at a 43% higher risk of cardiovascular events. GlaxoSmithKline publicly denounced the findings, but internal emails since released and included as part of the Senate Finance Committee report indicate that company scientists felt the company’s own numbers were similar to Dr. Nissen’s.
“The company has faced criticism that it has known about the heart-attack risks associated with Avandia for years. Glaxo added a “black box” warning to Avandia in November 2007 that says the drug can cause or exacerbate congestive heart failure.
The company has also faced accusations that it attempted to intimidate scientists and doctors outside the company who raised questions about the safety of Avandia. The company has said that it didn’t try to intimidate anyone. (The Wall Street Journal).”
If you or a loved one has suffered injury as a result of Avandia® use, contact a personal injury lawyer at the Maher Law Firm. You may be entitled to compensation for your injuries.
At the Maher Law Firm, our experienced attorneys are currently investigating claims involving Avandia®, a popular prescription pharmaceutical used to treat type 2 diabetes. Our lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers. We have handled lawsuits involving potentially harmful pharmaceuticals (including numerous claims involving Reglan® and Yaz®).
If you contact our attorneys for a free consultation, please bring the following information:
Our legal team will represent you intelligently and aggressively. To speak with a trial-tested lawyer – one familiar with Avandia®’s potential side effects – contact the Maher Law Firm today.